Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
about
Mechanisms of drug resistance: daptomycin resistanceTop Guns: The "Maverick" and "Goose" of Empiric Therapy.CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant EnterococciCombination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.Pharmacodynamics of teicoplanin against MRSA.Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.Antibiotics in Development for the Treatment of Resistant Bacterial Disease.Antibiotics: Synergistic MRSA combinations.
P2860
Q26779944-35A5F812-A21D-4DEF-8969-14E1C4AE1282Q30278491-62170BEA-0D7C-41C1-9301-1EA2F22E1C8AQ36748977-A28A8E51-140F-4BC7-BDA8-713463200BF1Q38425879-F11E1327-2BE1-4180-8FB8-842F30AE6FF0Q39516822-C46863D9-0004-434A-8765-5FB39B9C57EAQ41869403-4435CB63-A24D-4AB6-9A5A-C1DD83AEC751Q41992893-904049D9-77F9-4642-87D8-A5EE0ED37EB3Q48595162-13B3999E-49F9-43CF-B130-6285E9968EA1Q49829796-DA5FF5DE-C6A6-4D74-8343-4E4C6068505BQ50055030-D332D67B-8FA1-4CEF-997D-D3BC78BBF4A9Q53812943-2321B878-0DF1-4651-9CEA-B135ACE701EC
P2860
Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evaluation of vancomycin in co ...... e S. aureus isolates in vitro.
@en
type
label
Evaluation of vancomycin in co ...... e S. aureus isolates in vitro.
@en
prefLabel
Evaluation of vancomycin in co ...... e S. aureus isolates in vitro.
@en
P2093
P2860
P356
P1476
Evaluation of vancomycin in co ...... e S. aureus isolates in vitro.
@en
P2093
Jora Sliwinski
Keenan Ryan
Monique Dodd
Renée-Claude Mercier
Thomas J Dilworth
P2860
P304
P356
10.1128/AAC.01888-13
P407
P577
2013-11-25T00:00:00Z